Baird Financial Group’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.8M | Buy |
98,276
+225
| +0.2% | +$48.5K | 0.03% | 352 |
|
|
2025
Q4 | $20.1M | Sell |
98,051
-1,218
| -1% | -$229K | 0.03% | 374 |
|
|
2025
Q3 | $15.6M | Sell |
99,269
-124
| -0.1% | -$19.2K | 0.03% | 433 |
|
|
2025
Q2 | $16.7M | Buy |
99,393
+51,416
| +107% | +$7.63M | 0.03% | 399 |
|
|
2025
Q1 | $6.61M | Sell |
47,977
-1,763
| -4% | -$225K | 0.01% | 593 |
|
|
2024
Q4 | $5.88M | Sell |
49,740
-239
| -0.5% | -$27.9K | 0.01% | 636 |
|
|
2024
Q3 | $5.52M | Sell |
49,979
-7,654
| -13% | -$800K | 0.01% | 651 |
|
|
2024
Q2 | $5.67M | Sell |
57,633
-33,439
| -37% | -$3.41M | 0.01% | 627 |
|
|
2024
Q1 | $10.2M | Sell |
91,072
-2,061
| -2% | -$222K | 0.02% | 463 |
|
|
2023
Q4 | $9.39M | Buy |
93,133
+1,319
| +1% | +$131K | 0.02% | 464 |
|
|
2023
Q3 | $7.97M | Sell |
91,814
-2,874
| -3% | -$260K | 0.02% | 489 |
|
|
2023
Q2 | $8.95M | Buy |
94,688
+19,166
| +25% | +$1.62M | 0.02% | 470 |
|
|
2023
Q1 | $5.7M | Sell |
75,522
-9,741
| -11% | -$735K | 0.01% | 552 |
|
|
2022
Q4 | $6.55M | Buy |
85,263
+8,154
| +11% | +$620K | 0.02% | 522 |
|
|
2022
Q3 | $5.14M | Sell |
77,109
-479
| -0.6% | -$30.4K | 0.02% | 557 |
|
|
2022
Q2 | $4.06M | Sell |
77,588
-1,990
| -3% | -$113K | 0.01% | 629 |
|
|
2022
Q1 | $4.51M | Buy |
79,578
+432
| +0.5% | +$23.1K | 0.01% | 651 |
|
|
2021
Q4 | $4.08M | Buy |
79,146
+18,069
| +30% | +$886K | 0.01% | 673 |
|
|
2021
Q3 | $3.02M | Buy |
61,077
+1,705
| +3% | +$92.5K | 0.01% | 776 |
|
|
2021
Q2 | $3.39M | Buy |
59,372
+463
| +0.8% | +$27.1K | 0.01% | 723 |
|
|
2021
Q1 | $3.58M | Buy |
58,909
+1,497
| +3% | +$82.6K | 0.01% | 680 |
|
|
2020
Q4 | $3.08M | Buy |
57,412
+1,853
| +3% | +$96.1K | 0.01% | 678 |
|
|
2020
Q3 | $2.61M | Buy |
55,559
+1,689
| +3% | +$86.7K | 0.01% | 667 |
|
|
2020
Q2 | $2.81M | Buy |
53,870
+5,536
| +11% | +$285K | 0.01% | 635 |
|
|
2020
Q1 | $2.32M | Buy |
48,334
+41,118
| +570% | +$2.13M | 0.01% | 644 |
|
|
2019
Q4 | $365K | Sell |
7,216
-16,769
| -70% | -$866K | ﹤0.01% | 1264 |
|
|
2019
Q3 | $1.13M | Buy |
23,985
+1,499
| +7% | +$68.4K | ﹤0.01% | 940 |
|
|
2019
Q2 | $1.06M | Sell |
22,486
-21,587
| -49% | -$996K | ﹤0.01% | 962 |
|
|
2019
Q1 | $2.12M | Sell |
44,073
-13,450
| -23% | -$674K | 0.01% | 642 |
|
|
2018
Q4 | $2.57M | Buy |
57,523
+10,108
| +21% | +$527K | 0.02% | 570 |
|
|
2018
Q3 | $2.56M | Sell |
47,415
-134
| -0.3% | -$6.86K | 0.02% | 605 |
|
|
2018
Q2 | $2.32M | Buy |
47,549
+4,881
| +11% | +$277K | 0.02% | 613 |
|
|
2018
Q1 | $2.67M | Sell |
42,668
-8,446
| -17% | -$579K | 0.02% | 558 |
|
|
2017
Q4 | $3.13M | Sell |
51,114
-28,296
| -36% | -$1.75M | 0.02% | 514 |
|
|
2017
Q3 | $5.31M | Buy |
79,410
+14,981
| +23% | +$1.06M | 0.04% | 404 |
|
|
2017
Q2 | $5.02M | Sell |
64,429
-11,250
| -15% | -$849K | 0.04% | 402 |
|
|
2017
Q1 | $6.17M | Buy |
75,679
+11,797
| +18% | +$929K | 0.05% | 348 |
|
|
2016
Q4 | $4.6M | Sell |
63,882
-32,511
| -34% | -$2.35M | 0.04% | 389 |
|
|
2016
Q3 | $7.49M | Buy |
96,393
+2,447
| +3% | +$198K | 0.07% | 291 |
|
|
2016
Q2 | $7.47M | Buy |
93,946
+11,157
| +13% | +$889K | 0.07% | 290 |
|
|
2016
Q1 | $6.79M | Sell |
82,789
-173
| -0.2% | -$14.1K | 0.06% | 292 |
|
|
2015
Q4 | $7.41M | Buy |
82,962
+4,245
| +5% | +$360K | 0.07% | 270 |
|
|
2015
Q3 | $6.05M | Buy |
78,717
+12,366
| +19% | +$1.03M | 0.06% | 289 |
|
|
2015
Q2 | $5.55M | Buy |
+66,351
| New | +$5.86M | 0.05% | 314 |
|
Other funds holding CAH
VCM
VPM
Baird Financial Group's CAH Position: Q1 2026 in Review
Baird Financial Group increased its Cardinal Health (CAH) stake by 0.23% in Q1 2026, buying an estimated $48.5K and bringing the position to 98,276 shares worth $20.8M. The position accounts for 0.03% of the portfolio, ranked #352.
Baird Financial Group first reported a position in CAH in Q2 2015 and has held it in 44 quarters since. 1,423 funds tracked by Wall St. Rank hold CAH as of Q1 2026.
- Baird Financial Group held 98,276 shares of Cardinal Health worth $20.8M as of Q1 2026.
- Baird Financial Group bought 225 Cardinal Health shares in Q1 2026, an estimated $48.5K.
- Cardinal Health made up 0.03% of Baird Financial Group's portfolio in Q1 2026, its #352 holding.
- Baird Financial Group first reported a position in Cardinal Health in Q2 2015 and has held it in 44 quarters since.
- 1,423 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.
Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.